These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28981968)

  • 1. Omalizumab could be effective in children with severe eosinophilic non-allergic asthma.
    Bourgoin-Heck M; Amat F; Trouvé C; Bernard A; Magny JP; Lambert N; Just J
    Pediatr Allergy Immunol; 2018 Feb; 29(1):90-93. PubMed ID: 28981968
    [No Abstract]   [Full Text] [Related]  

  • 2. Omalizumab in patients with eosinophilic granulomatosis with polyangiitis: a 36-month follow-up study.
    Detoraki A; Di Capua L; Varricchi G; Genovese A; Marone G; Spadaro G
    J Asthma; 2016; 53(2):201-6. PubMed ID: 26377630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omalizumab is effective and available for treatment of patients with severe allergic asthma in Poland.
    Zastrzeżyńska W; Gawlewicz-Mroczka A; Soja J; Sładek K; Musiał J; Bazan-Socha S
    Pol Arch Intern Med; 2017 Oct; 127(10):715-717. PubMed ID: 29162793
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of omalizumab on eosinophilic inflammation of the respiratory tract in patients with allergic asthma.
    Kupryś-Lipińska I; Molińska K; Kuna P
    Pneumonol Alergol Pol; 2016; 84(4):232-43. PubMed ID: 27435350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omalizumab in Japanese children with severe allergic asthma uncontrolled with standard therapy.
    Odajima H; Ebisawa M; Nagakura T; Fujisawa T; Akasawa A; Ito K; Doi S; Yamaguchi K; Katsunuma T; Kurihara K; Kondo N; Sugai K; Nambu M; Hoshioka A; Yoshihara S; Sato N; Seko N; Nishima S
    Allergol Int; 2015 Oct; 64(4):364-70. PubMed ID: 26433533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-life long-term omalizumab therapy in children with severe allergic asthma.
    Deschildre A; Marguet C; Langlois C; Pin I; Rittié JL; Derelle J; Abou Taam R; Fayon M; Brouard J; Dubus JC; Siret D; Weiss L; Pouessel G; Beghin L; Just J
    Eur Respir J; 2015 Sep; 46(3):856-9. PubMed ID: 26022964
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe asthma with eosinophilic gastroenteritis effectively managed by mepolizumab and omalizumab.
    Han D; Lee JK
    Ann Allergy Asthma Immunol; 2018 Dec; 121(6):742-743. PubMed ID: 30056148
    [No Abstract]   [Full Text] [Related]  

  • 8. Omalizumab therapy in a 13-year-old boy with severe persistent asthma and concomitant eosinophilic esophagitis.
    Arasi S; Costa S; Magazzù G; Ieni A; Crisafulli G; Caminiti L; Chiera F; Vaccaro M; Del Giudice MM; Pajno GB
    Ital J Pediatr; 2016 Mar; 42():32. PubMed ID: 27000314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mepolizumab in adolescents with severe eosinophilic asthma not eligible for omalizumab: one center's early clinical experience.
    Weir E; Paton J
    J Asthma; 2020 May; 57(5):521-524. PubMed ID: 30795693
    [No Abstract]   [Full Text] [Related]  

  • 10. Omalizumab discontinuation in children with severe allergic asthma: An observational real-life study.
    Deschildre A; Roussel J; Drumez E; Abou-Taam R; Rames C; Le Roux P; Pouessel G; Scalbert M; Bonnel C; Mitha S; Boileau S; Mordacq C; Thumerelle C; Labreuche J; Lejeune S; Marguet C
    Allergy; 2019 May; 74(5):999-1003. PubMed ID: 30481388
    [No Abstract]   [Full Text] [Related]  

  • 11. Omalizumab Is Associated with Reduced Acute Severity of Rhinovirus-triggered Asthma Exacerbation.
    Kantor DB; McDonald MC; Stenquist N; Schultz BJ; Smallwood CD; Nelson KA; Phipatanakul W; Hirschhorn JN
    Am J Respir Crit Care Med; 2016 Dec; 194(12):1552-1555. PubMed ID: 27976938
    [No Abstract]   [Full Text] [Related]  

  • 12. Biomarkers for severe allergic asthma in children: could they be useful to guide disease control and use of omalizumab?
    Amat F; Labbé A
    Expert Rev Respir Med; 2018 Jun; 12(6):475-482. PubMed ID: 29741411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The discovery and development of omalizumab for the treatment of asthma.
    Licari A; Marseglia G; Castagnoli R; Marseglia A; Ciprandi G
    Expert Opin Drug Discov; 2015; 10(9):1033-42. PubMed ID: 25979110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omalizumab in children with uncontrolled allergic asthma: Review of clinical trial and real-world experience.
    Chipps BE; Lanier B; Milgrom H; Deschildre A; Hedlin G; Szefler SJ; Kattan M; Kianifard F; Ortiz B; Haselkorn T; Iqbal A; Rosén K; Trzaskoma B; Busse WW
    J Allergy Clin Immunol; 2017 May; 139(5):1431-1444. PubMed ID: 28477722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to omalizumab in patients with severe allergic asthma: A real-life study.
    Zierau L; Walsted ES; Thomsen SF; Backer V
    Respir Med; 2017 Oct; 131():109-113. PubMed ID: 28947015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Severe uncontrolled asthma in patients over 75 years old: Treatment with omalizumab].
    Romand P; Kelkel E; Saint-Raymond C; Glas N; Caillaud D; Devouassoux G
    Rev Mal Respir; 2016 May; 33(5):397-400. PubMed ID: 26346416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of omalizumab add-on to standard-of-care therapy in patients with uncontrolled severe allergic asthma in a Brazilian healthcare setting.
    Suzuki C; Lopes da Silva N; Kumar P; Pathak P; Ong SH
    J Med Econ; 2017 Aug; 20(8):832-839. PubMed ID: 28532191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of asthma by omalizumab: the role of CD4
    Amat F; Tallon P; Foray AP; Michaud B; Lambert N; Saint-Pierre P; Chatenoud L; Just J
    Clin Exp Allergy; 2016 Dec; 46(12):1614-1616. PubMed ID: 27770456
    [No Abstract]   [Full Text] [Related]  

  • 19. Long term outcome of Omalizumab Therapy in childhood severe allergic asthma.
    Mariana D
    Med J Malaysia; 2021 May; 76(3):422-425. PubMed ID: 34031345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omalizumab, an additional therapy for allergic bronchopulmonary aspergillosis.
    Evans MO; Morris MJ; Coop CA; Evans SE
    Ann Allergy Asthma Immunol; 2015 Sep; 115(3):250-1. PubMed ID: 26162570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.